NCT03766516View on ClinicalTrials.gov

Registry of BrentuximabVedotinin Patients With R/R Anaplastic Large Cell Lymphoma or Classical HL

CompletedOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

December 30, 2021

Study Completion Date

December 30, 2021

Conditions
Relapsed or Refractory Anaplastic Large Cell Lymphoma & Hodgkin Lymphoma
Trial Locations (1)

06351

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT03766516 - Registry of BrentuximabVedotinin Patients With R/R Anaplastic Large Cell Lymphoma or Classical HL | Biotech Hunter | Biotech Hunter